Market Tracker

08/29 5:16pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.80
Delayed Data
As of 4:00pm ET
 -0.02 / -0.20%
Today’s Change
6.96
Today|||52-Week Range
19.63
-43.45%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close9.82
Today’s open9.88
Day’s range9.53 - 9.90
Volume937,782
Average volume (3 months)1,345,539
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-263.75%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book29.27

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.14-0.48%
FPRXFive Prime Therapeut...+0.51+1.14%
XLRNAcceleron Pharma Inc+0.07+0.23%
ONCESpark Therapeutics I...-0.02-0.04%
Data as of 4:00pm ET, 08/29/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts